ALLO vs BIIB: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Biogen Inc in 2026
ALLO
Allogene Therapeutics Inc
$2.15
BIIB
Biogen Inc
$183.41
Key Metrics Comparison
| Metric | ALLO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $510.14M | $26.92B | BIIB |
| P/E Ratio | N/A | 20.87 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze ALLO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or BIIB a better investment?
Comparing ALLO and BIIB: Allogene Therapeutics Inc has a market cap of $510.14M while Biogen Inc has $26.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and BIIB?
ALLO (Allogene Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for ALLO.
Which company is more profitable: ALLO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for ALLO.
Which is the larger company: ALLO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.92B compared to $510.14M for ALLO.
Should I buy ALLO or BIIB in 2026?
Both ALLO and BIIB have investment merit. ALLO trades at $2.15 while BIIB trades at $183.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and BIIB stock?
Key differences: Market Cap ($510.14M vs $26.92B), P/E Ratio (N/A vs 20.9x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).